title: Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
authors.affiliation: From Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
authors.forename: Scott A
authors.initials: SA
authors.lastname: Hubers
authors.affiliation: From Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
authors.forename: Nancy J
authors.initials: NJ
authors.lastname: Brown
mesh_terms: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D015260:Neprilysin; D011945:Receptors, Angiotensin; D013777:Tetrazoles / Q000627:therapeutic use
chemical_list: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D015260:Neprilysin